A federal district court judge yesterday ruled that the Department of Health and Human Services would get "first crack at crafting appropriate remedial measures" to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program. He also held that, like the 2018 cuts, the 2019 cuts to 340B hospitals were unlawful. The judge said that he expected HHS to “act expeditiously to resolve these issues” and required HHS to report back to him on or before Aug. 5 with its remedy proposal.
 
In a statement, the AHA, Association of American Medical Colleges and America’s Essential Hospitals said, “America’s 340B hospitals are pleased with the District Court’s decision and urge HHS to follow the judge’s directive to promptly resolve the harm caused by its unlawful cuts to Medicare reimbursement for certain 340B hospitals.” The groups also urged HHS to “promptly comply with the judge’s ruling and restore to 340B hospitals all funds that have been unlawfully withheld.” 

A federal judge Dec. 27 ruled in favor of the AHA and hospital plaintiffs that HHS's nearly 30 percent cut of 2018 Medicare payment rates for many hospitals in the 340B program was unlawful. The lawsuit was brought by the AHA, AAMC, AEH and three hospital plaintiffs.

Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1. Data…
Headline
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
The AHA Aug. 17 provided comments to the Centers for Medicare & Medicaid Services on its proposed rule to codify in regulation the Medicare Drug Price…
Headline
The Centers for Medicare & Medicaid Services Aug. 7 released a procedural notice on its new pathway to expedite access to certain Food and Drug…